Konstantinos Tsarouhas Selected Research

Konstantinos Tsarouhas Research Topics

Disease

9	Inflammation (Inflammations) 01/2023 - 08/2011
7	Cardiotoxicity 11/2021 - 01/2016
6	Poisoning 11/2021 - 03/2016
4	Neoplasms (Cancer) 04/2023 - 01/2017
4	Necrosis 11/2021 - 10/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2017
3	Ischemia 11/2021 - 03/2016
3	Acute Kidney Injury (Acute Renal Failure) 04/2020 - 10/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 11/2022
2	Stroke (Strokes) 08/2019 - 01/2019
2	Hypoxia (Hypoxemia) 01/2019 - 09/2016
2	Insulin Resistance 12/2014 - 11/2011
1	Parkinson Disease (Parkinson's Disease) 12/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2022
1	Neuroinflammatory Diseases 11/2022
1	Dyslipidemias (Dyslipidemia) 07/2022
1	COVID-19 04/2022
1	Virus Diseases (Viral Diseases) 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Pulmonary Embolism 12/2021
1	Fatigue 12/2021
1	Hyperalgesia 12/2020
1	Neuralgia (Stump Neuralgia) 12/2020
1	Pain (Aches) 09/2020
1	Silicosis 08/2020
1	Lung Diseases (Lung Disease) 08/2020
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Hypertension (High Blood Pressure) 06/2020
1	Erectile Dysfunction 04/2020
1	Eosinophilia 08/2019
1	Arthritis (Polyarthritis) 08/2019
1	Endocarditis 08/2019
1	Ischemic Stroke 08/2019
1	Hemorrhagic Stroke 08/2019
1	Abdominal Obesity 04/2019
1	Fibrosis (Cirrhosis) 02/2019
1	Rubella (German Measles) 01/2019
1	Hemorrhage 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Cardiovascular Abnormalities 01/2019
1	Airway Obstruction (Choking) 04/2018

Drug/Important Bio-Agent (IBA)

5	Carbon MonoxideIBA 11/2021 - 03/2016
3	AntioxidantsIBA 11/2022 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2021
2	CytokinesIBA 11/2022 - 09/2020
2	LipidsIBA 07/2022 - 11/2011
2	HesperidinIBA 11/2021 - 06/2020
2	AnthracyclinesIBA 10/2020 - 09/2020
2	crocinIBA 09/2020 - 06/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 08/2020 - 11/2016
2	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2019 - 02/2018
2	Contrast MediaIBA 12/2017 - 10/2017
2	Messenger RNA (mRNA)IBA 04/2017 - 11/2011
2	oxidized low density lipoproteinIBA 01/2017 - 12/2014
2	HomocysteineIBA 11/2011 - 08/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 12/2022
1	Glutamic Acid (Glutamate)FDA Link 11/2022
1	cerebrolysinIBA 11/2022
1	Lipoprotein(a)IBA 07/2022
1	antineoplaston A10 (A 10)IBA 07/2022
1	MicronutrientsIBA 04/2022
1	Antiviral Agents (Antivirals)IBA 04/2022
1	Clostridium perfringens epsilon-toxinIBA 12/2021
1	AntidotesIBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2021
1	FlavonoidsIBA 11/2021
1	Saline SolutionIBA 12/2020
1	Imipramine (Janimine)FDA LinkGeneric 12/2020
1	Lipoxygenase (Lipoxygenase-1)IBA 12/2020
1	coumarinIBA 12/2020
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	umbellipreninIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020
1	PowdersIBA 08/2020
1	Phosphodiesterase 5 InhibitorsIBA 04/2020
1	Anabolic Androgenic SteroidsIBA 08/2019
1	Morphine (MS Contin)FDA LinkGeneric 08/2019
1	CannabinoidsIBA 08/2019
1	Heroin (Diamorphine)IBA 08/2019
1	AmphetaminesIBA 08/2019
1	Opiate AlkaloidsIBA 08/2019
1	Cocaine (Cocaine HCl)IBA 08/2019
1	Triglycerides (Triacylglycerol)IBA 04/2019
1	Blood Glucose (Blood Sugar)IBA 04/2019
1	HDL CholesterolIBA 04/2019
1	GadoliniumIBA 02/2019
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	PlasminogenIBA 01/2019
1	Bronchodilator Agents (Bronchodilators)IBA 04/2018

Therapy/Procedure

4	Therapeutics 04/2022 - 01/2017
1	Percutaneous Coronary Intervention 07/2022
1	Drug Therapy (Chemotherapy) 01/2019
1	Renal Dialysis (Hemodialysis) 01/2019
1	Radiotherapy 01/2019
1	Contraindications 01/2019